Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 319Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Kybella/Belkyra

PharmaCompass

01

Brand Name : Kybella/Belkyra

arrow
Antibody Engineering
Not Confirmed

Deoxycholic Acid

Main Therapeutic Indication : Submental Fat

Currency : USD

2017 Revenue in Millions : 56

2016 Revenue in Millions : 53

Growth (%) : 7

Abbvie CB

02

Brand Name : Kybella/Belkyra

arrow
Antibody Engineering
Not Confirmed

Deoxycholic Acid

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 38

2017 Revenue in Millions : 56

Growth (%) : -32%

Abbvie CB

03

Brand Name : Kybella/Belkyra

arrow
Antibody Engineering
Not Confirmed

Deoxycholic Acid

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 31

2018 Revenue in Millions : 38

Growth (%) : -19

Abbvie CB

04

Brand Name : Kybella/Belkyra

arrow
Antibody Engineering
Not Confirmed

Deoxycholic Acid

Main Therapeutic Indication : Submental Fat

Currency : USD

2016 Revenue in Millions : 53

2015 Revenue in Millions : 3

Growth (%) : 1,667

Abbvie CB